IQVIA Solutions B.V.

Tweet this page
<
2023
2024
>
No longer registered as of 10 Jan 2025 - Registration as it was on 08 Jan 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

200,000€ - 299,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

2.5 Fte (6)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    IQVIA Solutions B.V.   (IQVIA)

    EU Transparency Register

    919364748546-26 First registered on 08 Jan 2023

    Goals / Remit

    IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry dedicated to creating intelligent connections that deliver unique innovations and actionable insights.

    Main EU files targeted

    Proposed Regulation for European Health Data Space
    Ongoing revision of the General Data Protection Regulation
    Proposed Regulation laying down harmonised rules on Artificial Intelligence (Artificial Intelligence Act)
    Ongoing implementing of the Regulation on Health Technology Assessment
    Proposed revision by EC (DG SANTE) of the general pharmaceutical legislation
    Ongoing discussion around medicines shortages
    Ongoing discussion on AMR (antimicrobial resistance): incentives for development of new antibiotics; securing supplies/continuation of existing antibiotics; and bring back to the market older antibiotics that have been discontinued

    Address

    Head Office
    Herikerbergweg 314
    Amsterdam 1101 CT
    NETHERLANDS
    EU Office
    Herikerbergweg 314
    Amsterdam 1101 CT
    NETHERLANDS

    Website

    www.iqvia.com

  • People

    Total lobbyists declared

    6

    Employment timeLobbyists
    50%4
    25%2

    Lobbyists (Full time equivalent)

    2.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Digital Health Society (https://thedigitalhealthsociety.com)
    European Connected Healthcare Alliance (https://echalliance.com)
    Partners in Research (for IHI: https://www.ihi.europa.eu)

    Member organisations

    Part of the IQVIA group (www.iqvia.com) with subsidiaries and partner companies in all EU member states

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    200,000€ - 299,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    200,000€ - 299,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    Several reports have been published by the IQVIA Institute that are relevant to the EU policy debate on pharmaceutical policies: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports

    IQVIA sponsored an event on medicines shortages organised by GIRP (www.girp.eu) at the European Health Forum Gastein (www.ehfg.org)

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below covers meetings with Commissioners/Cabinet members/Directors-general (high-level) Commission meetings published December 2014 to December 2024, and the meetings of Commissioners/Cabinet members/Directors-general and officials holding "management functions" in the Commission published since 1 January 2025. Other lobby meetings with lower-level staff may well have taken place, but the Commission doesn't proactively publish information about these meetings. All information below comes from the Commission and not from the registrant.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 26 Feb 2025 Location Boston, United States
      Subject Healthcare, biotech and agri-food policies
      Cabinet Cabinet of Commissioner Olivér Várhelyi
      Attending
      • Olivér Várhelyi (Commissioner)
      • Laszlo Andrejko (Cabinet member)
      • Laszlo Kristoffy (Cabinet member)
      Other Lobbyists
Download this datacard